Intravenous calcium salts for hyperkalemia-associated ECG abnormalities: a systematic review
DOI:
https://doi.org/10.65759/639ypc57Keywords:
hyperkalemia, calcium gluconate, calcium chloride, electrocardiography, arrhythmiaAbstract
Background: Intravenous (IV) calcium salts are recommended for hyperkalemia with electrocardiographic (ECG) abnormalities to stabilize myocardial excitability. The clinical evidence support this practice is limited and heterogeneous. We aimed to systematically review articles about IV calcium salts, calcium gluconate or calcium chloride, for hyperkalemia associated ECG abnormalities. Methods: A PRISMA based systematic review was designed for PubMed, Scopus, and Web of Science. Eligible studies were original human studies, prospective, retrospective cohorts, case series, and case reports, about hyperkalemia associated ECG abnormalities and administration of IV calcium salts with reported ECG or short term response. Reviews, editorials, and purely non-interventional ECG association studies were excluded. We extract data about study design, patient characteristics, potassium level, ECG findings, calcium salt, dose, co-interventions, and reported response. Results: Ten original studies were included. Most reports used IV calcium gluconate, one case show early calcium chloride IV push, and one recurrent arrest episode included calcium chloride during resuscitation. In case reports, ECG abnormalities included third degree AV block, severe bradyarrhythmia, sinus arrest with escape rhythms, QRS widening, and conduction disturbances in BRASH syndrome. Clear immediate clinical improvement associated with IV calcium was described in several cases as shock reversal, QRS narrowing, and rhythm stabilization, but attribution was confounded by concurrent insulin dextrose, beta agonists, bicarbonate, and dialysis. The largest prospective cohort found no significant effect on non-rhythm ECG abnormalities but a significant improvement in a subset of rhythm disorders. Conclusions: IV calcium salts for hyperkalemia associated ECG abnormalities is dominated by low level evidence plus one single center prospective observational study showing limited benefit in rhythm disturbances.
References
1. Al Aseri Z. Calcium salt administration for circulatory shock due to severe hyperkalemia. Saudi J Anaesth. 2019 Jul-Sep;13(3):240-242. doi: 10.4103/sja.SJA_708_18. PMID: 31333371; PMCID: PMC6625307.
2. An JN, Lee JP, Jeon HJ, Kim DH, Oh YK, Kim YS, Lim CS. Severe hyperkalemia requiring hospitalization: predictors of mortality. Crit Care. 2012 Nov 21;16(6):R225. doi: 10.1186/cc11872. PMID: 23171442; PMCID: PMC3672605.
3. Bisogno JL, Langley A, Von Dreele MM. Effect of calcium to reverse the electrocardiographic effects of hyperkalemia in the isolated rat heart: a prospective, dose-response study. Crit Care Med. 1994 Apr;22(4):697-704. PMID: 8143480.
4. Celebi Yamanoglu NG, Yamanoglu A. The effect of calcium gluconate in the treatment of hyperkalemia. Turk J Emerg Med. 2022 Apr 11;22(2):75-82. doi: 10.4103/2452-2473.342812. PMID: 35529029; PMCID: PMC9069919.
5. Drennan IR, et al. Advanced Life Support: 2025 International Liaison Committee on Resuscitation/AHA consensus (includes hyperkalemia treatment recommendations). 2025
6. Durfey N, Lehnhof B, Bergeson A, Durfey SNM, Leytin V, McAteer K, Schwam E, Valiquet J. Severe Hyperkalemia: Can the Electrocardiogram Risk Stratify for Short-term Adverse Events? West J Emerg Med. 2017 Aug;18(5):963-971. doi: 10.5811/westjem.2017.6.33033. Epub 2017 Jul 10. PMID: 28874951; PMCID: PMC5576635.
7. Elmoheen A, Mishreky LM, Albeiruti S, Elanani RH, Azad A. Severe Persistent Hyperkalemia with Electrocardiogram Changes in a Patient with Hyperaldosteronism. Cureus. 2020 Nov 6;12(11):e11358. doi: 10.7759/cureus.11358. PMID: 33178543; PMCID: PMC7651772.
8. Gebray HM, Abeje AE, Boye AT. BRASH syndrome with a complete heart block- a case report. BMC Cardiovasc Disord. 2024 Feb 19;24(1):114. doi: 10.1186/s12872-024-03782-6. PMID: 38373878; PMCID: PMC10877849.
9. Hasnie AA, Baniahmad O, Tolwani A, McElderry HT, Prabhu SD. Complete heart block without ventricular escape secondary to hyperkalemia induced by herbal tea. HeartRhythm Case Rep. 2021 Nov 9;8(1):45-49. doi: 10.1016/j.hrcr.2021.11.004. PMID: 35070707; PMCID: PMC8767166.
10. Jessen MK, Andersen LW, Djakow J, Chong NK, Stankovic N, Staehr C, Vammen L, Petersen AH, Johannsen CM, Eggertsen MA, Mortensen SØ, Høybye M, Nørholt C, Holmberg MJ, Granfeldt A; International Liaison Committee on Resuscitation (ILCOR) Advanced Paediatric Life Support Task Forces. Pharmacological interventions for the acute treatment of hyperkalaemia: A systematic review and meta-analysis. Resuscitation. 2025 Mar;208:110489. doi: 10.1016/j.resuscitation.2025.110489. Epub 2025 Jan 4. PMID: 39761907.
11. Johnson D, Wiener D. Severe Hyperkalemia, a Case Report. J Educ Teach Emerg Med. 2020 Jul 15;5(3):V1-V3. doi: 10.21980/J8KH1D. PMID: 37465225; PMCID: PMC10332545.
12. Lindner G, Burdmann EA, Clase CM, Hemmelgarn BR, Herzog CA, Małyszko J, Nagahama M, Pecoits-Filho R, Rafique Z, Rossignol P, Singer AJ. Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference. Eur J Emerg Med. 2020 Oct;27(5):329-337. doi: 10.1097/MEJ.0000000000000691. PMID: 32852924; PMCID: PMC7448835.
13. Okan T, Arastu A, Zarghami M, Patel V, Chinakwe U, Lasic Z. BRASH Phenomenon: A Case Report on the Dangerous Combination of Bradycardia, Acute Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia. Cureus. 2025 Aug 24;17(8):e90898. doi: 10.7759/cureus.90898. PMID: 40995280; PMCID: PMC12456856.
14. Piktel JS, Wan X, Kouk S, Laurita KR, Wilson LD. Beneficial Effect of Calcium Treatment for Hyperkalemia Is Not Due to "Membrane Stabilization". Crit Care Med. 2024 Oct 1;52(10):1499-1508. doi: 10.1097/CCM.0000000000006376. Epub 2024 Jul 24. PMID: 39046789; PMCID: PMC11410510.
15. Rafique Z, Peacock F, Armstead T, Bischof JJ, Hudson J, Weir MR, Neuenschwander J. Hyperkalemia management in the emergency department: An expert panel consensus. J Am Coll Emerg Physicians Open. 2021 Oct 1;2(5):e12572. doi: 10.1002/emp2.12572. PMID: 34632453; PMCID: PMC8485984.
16. Saad SM, Yasin S, Jain N, LeLorier P. Cardiac Manifestations in a Case of Severe Hyperkalemia. Cureus. 2021 Mar 1;13(3):e13641. doi: 10.7759/cureus.13641. PMID: 33824794; PMCID: PMC8012067.
17. Schnaubelt S, Niederdoeckl J, Schoergenhofer C, Cacioppo F, Schuetz N, Spiel AO, Hecking M, Domanovits H. Hyperkalemia: A persisting risk. A case report and update on current management. Clin Case Rep. 2020 Jun 2;8(9):1748-1753. doi: 10.1002/ccr3.2974. PMID: 32983489; PMCID: PMC7495804.
18. Soe KK, Seto AH. Sliding with the sines - fatal hyperkalemia: A case report. World J Cardiol. 2021 Jul 26;13(7):230-236. doi: 10.4330/wjc.v13.i7.230. PMID: 34367507; PMCID: PMC8326152.
19. UK Kidney Association Guideline Group (Alfonzo A, et al.). Management of Hyperkalaemia in Adults (2023 update) – guideline document (supporting practice context). 2023.
20. Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008 Dec;36(12):3246-51. doi: 10.1097/CCM.0b013e31818f222b. PMID: 18936701.
